Xylem (XYL) Stock Forecast & Price Target

Q: What analysts cover Xylem?

Xylem has been rated by research analysts at Argus , Barclays , BNP Paribas Exane , Citigroup , Jefferies Financial Group , JPMorgan Chase & Co. , Mizuho , Oppenheimer , Robert W. Baird , Royal Bank Of Canada , Stifel Nicolaus , The Goldman Sachs Group , UBS Group , Weiss Ratings , Wolfe Research , and Zacks Research in the past 90 days.

$94.56 +0.53 (+0.57%)

As of 11:11 AM Eastern

Compare

Xylem - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 19 Analyst Ratings

Sell
2

Hold
8

Buy
9

Based on 19 Wall Street analysts who have issued ratings for Xylem in the last 12 months, the stock has a consensus rating of "Hold." Out of the 19 analysts, 2 have given a sell rating, 8 have given a hold rating, and 9 have given a buy rating for XYL.

Consensus Price Target

$121.31
28.28% Upside

According to the 19 analysts' twelve-month price targets for Xylem, the average price target is $121.31. The highest price target for XYL is $150.00, while the lowest price target for XYL is $90.00. The average price target represents a forecasted upside of 28.28% from the current price of $94.56.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for XYL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Xylem and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XYL Analyst Ratings Over Time

Type	Current Forecast 11/13/25 to 11/13/26	1 Month Ago 10/14/25 to 10/14/26	3 Months Ago 8/15/25 to 8/15/26	1 Year Ago 11/13/24 to 11/13/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	9 Buy rating(s)	9 Buy rating(s)	9 Buy rating(s)	8 Buy rating(s)
Hold	8 Hold rating(s)	7 Hold rating(s)	6 Hold rating(s)	4 Hold rating(s)
Sell	2 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$121.31	$147.08	$154.23	$166.90
Forecasted Upside	28.28% Upside	43.26% Upside	28.79% Upside	13.17% Upside
Consensus Rating	Hold	Moderate Buy	Moderate Buy	Moderate Buy

XYL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

XYL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Xylem Stock vs. The Competition

Type	Xylem	Industrials Companies	Broader Market
Consensus Rating Score	2.37	2.29	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	28.86% Upside	53.53% Upside	13.84% Upside
News Sentiment Rating	Positive News See Recent XYL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
11/4/2026	Argus 3 of 5 stars	John Eade 2 of 5 stars	Downgrade	Buy ➝ Hold
10/29/2026	Zacks Research 4 of 5 stars		Downgrade	Hold ➝ Strong Sell
10/29/2026	UBS Group 4 of 5 stars	Joshua Spector 4 of 5 stars	Lower Target	Neutral	$112.00 ➝ $99.00	+10.14%
10/28/2026	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	William Grippin Subscribe to MarketBeat All Access to unlock analyst rankings	Downgrade	Overweight ➝ Equal Weight	$139.00 ➝ $104.00	+17.76%
10/28/2026	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings		Downgrade	Hold (C) ➝ Sell (D)
10/28/2026	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Brett Linzey Subscribe to MarketBeat All Access to unlock analyst rankings	Set Target		$99.00	+12.63%
10/28/2026	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Michael Halloran Subscribe to MarketBeat All Access to unlock analyst rankings	Set Target		$123.00	+39.93%
10/28/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Brian Lee Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Buy	$160.00 ➝ $138.00	+48.16%
10/28/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Jeffrey Reive Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Outperform	$135.00 ➝ $125.00	+34.20%
10/28/2026	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Andrew Kaplowitz Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Buy	$148.00 ➝ $130.00	+47.20%
Get the Latest News and Ratings for XYL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Xylem and its competitors with MarketBeat's FREE daily newsletter.
10/28/2026	BNP Paribas Exane Subscribe to MarketBeat All Access to unlock brokerage rankings	Andrew Buscaglia Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Outperform	$145.00 ➝ $135.00	+53.20%
10/28/2026	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Nathan Jones Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Buy	$141.00 ➝ $114.00	+28.53%
10/28/2026	Oppenheimer Subscribe to MarketBeat All Access to unlock brokerage rankings	Bryan Blair Subscribe to MarketBeat All Access to unlock analyst rankings	Lower Target	Outperform	$150.00 ➝ $135.00	+44.94%
10/28/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access to unlock brokerage rankings	Mark Strouse Subscribe to MarketBeat All Access to unlock analyst rankings	Downgrade	Overweight ➝ Neutral	$118.00 ➝ $90.00	-3.37%
9/15/2026	Wolfe Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Nigel Coe Subscribe to MarketBeat All Access to unlock analyst rankings	Initiated Coverage	Peer Perform
8/24/2026	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Stephen Volkmann Subscribe to MarketBeat All Access to unlock analyst rankings	Boost Target	Buy	$145.00 ➝ $150.00	+31.92%
6/25/2026	CLSA Subscribe to MarketBeat All Access to unlock brokerage rankings		Upgrade	Hold
2/23/2026	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Joseph Giordano Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Hold
1/26/2026	William Blair Subscribe to MarketBeat All Access to unlock brokerage rankings	Brian Drab Subscribe to MarketBeat All Access to unlock analyst rankings	Initiated Coverage	Outperform
5/15/2025	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Bobby Zolper Subscribe to MarketBeat All Access to unlock analyst rankings	Upgrade	Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 11:11 AM ET.

Should I Buy Xylem Stock? XYL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, November 10, 2026. Please send any questions or comments about these Xylem pros and cons to contact@marketbeat.com.

Xylem
Bull Case

Here are some ways that investors could benefit from investing in Xylem Inc.:

The stock is currently trading at $96.78, which is significantly below the average analyst price target of $121.31, suggesting substantial upside potential for investors who believe the recent sell-off has overcorrected the company's value.
Xylem Inc. has completed the acquisition of Cornell Pump and Roper Pump, a strategic move that expands its product portfolio and strengthens its position in the water infrastructure and industrial machinery sectors.
Demand for the company's Applied Water segment is surging, with data center orders growing over 200% in the third quarter, indicating a strong tailwind from the expanding AI and data center infrastructure buildout.
Director D Christian Koch purchased 11,000 shares of the company's stock on October 29, 2026, at an average price of $89.60, signaling insider confidence in the stock's long-term value at current levels.
The company offers a dividend yield of 1.73% with a payout ratio of 38.05%, providing a steady income stream for investors while maintaining a conservative approach to distributing earnings.

Xylem
Bear Case

Investors should be bearish about investing in Xylem Inc. for these reasons:

Xylem Inc. cut its full-year 2026 adjusted earnings per share outlook by as much as $0.25 per share, citing project delays and cautious customer spending, which has led to a securities investigation notice from law firms regarding potential claims.
The company's revenue for the most recent quarter was down 3.0% on a year-over-year basis, missing the consensus estimate of $2.28 billion with actual revenue of $2.20 billion, indicating softening demand in its core markets.
Argus downgraded Xylem Inc. from a "buy" rating to a "hold" rating, reflecting concerns about the company's valuation and recent performance relative to its peers in the industrial sector.
Institutional investors such as Pictet Asset Management Holding SA and Candriam S.C.A. have significantly reduced their stakes in the company during the third quarter, with Pictet lowering its position by 19.1% and Candriam by 10.8%, suggesting a lack of confidence among large holders.
The stock has experienced a significant decline from its fifty-two week high of $151.99 to its current price of $96.78, reflecting a broader market skepticism about the company's ability to maintain growth and profitability in the current economic environment.

XYL Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Xylem is $121.31, with a high forecast of $150.00 and a low forecast of $90.00.

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Xylem in the last twelve months. There are currently 2 sell ratings, 8 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" XYL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XYL, but not buy additional shares or sell existing shares.

According to analysts, Xylem's stock has a predicted upside of 28.28% based on their 12-month stock forecasts.

Over the previous 90 days, Xylem's stock had 5 downgrades by analysts.

Xylem has been rated by research analysts at Argus, Barclays, BNP Paribas Exane, Citigroup, Jefferies Financial Group, JPMorgan Chase & Co., Mizuho, Oppenheimer, Robert W. Baird, Royal Bank Of Canada, Stifel Nicolaus, The Goldman Sachs Group, UBS Group, Weiss Ratings, Wolfe Research, and Zacks Research in the past 90 days.

Analysts like Xylem more than other "industrials" companies. The consensus rating score for Xylem is 2.37 while the average consensus rating score for "industrials" companies is 2.29. Learn more on how XYL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Xylem Recommendations

MarketBeat monitors more than a dozen sources for Xylem analyst ratings, with the most recent rating issued on 11/4/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Xylem (XYL) Stock Forecast & Price Target